Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Löser

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pflege Zeitschrift|August 3, 2002
[Life-long learning in nursing care: not allowing progress to overtake knowledge]A P Löser
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 6, 2008
[Human embryonic stem cells within the context of international research activity]A M Wobus, P Löser
Biological Chemistry Hoppe-Seyler|March 1, 1996
Evaluation of HBV promoters for use in hepatic gene therapyP Löser, V Sandig, I Kirillova, et al.
Human Gene Therapy|June 28, 2001
System for efficient helper-dependent minimal adenovirus construction and rescueM Hillgenberg, F Schnieders, P Löser, et al.
Pneumologie (Stuttgart, Germany)|December 9, 2016
P Löser, B Mross, H Lapp, et al.
Journal of Virology|January 7, 1998
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaBP Löser, G S Jennings, M Strauss, et al.
Gene Therapy|February 4, 1999
Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approachK Brand, P Löser, W Arnold, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Gene therapy: prospects for treatment of liver diseaseV Sandig, C Hofmann, P Löser, et al.
Gene Therapy|November 1, 1996
HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor geneV Sandig, P Löser, A Lieber, et al.
Der Urologe. Ausg. A|November 1, 1979
[Spontaneous fistulae and abscesses of the upper urinary tract (author's transl)]E Schindler, H Zöckler, H U Braedel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pflege Zeitschrift|August 3, 2002
[Life-long learning in nursing care: not allowing progress to overtake knowledge]A P Löser
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 6, 2008
[Human embryonic stem cells within the context of international research activity]A M Wobus, P Löser
Biological Chemistry Hoppe-Seyler|March 1, 1996
Evaluation of HBV promoters for use in hepatic gene therapyP Löser, V Sandig, I Kirillova, et al.
Human Gene Therapy|June 28, 2001
System for efficient helper-dependent minimal adenovirus construction and rescueM Hillgenberg, F Schnieders, P Löser, et al.
Pneumologie (Stuttgart, Germany)|December 9, 2016
P Löser, B Mross, H Lapp, et al.
Journal of Virology|January 7, 1998
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaBP Löser, G S Jennings, M Strauss, et al.
Gene Therapy|February 4, 1999
Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approachK Brand, P Löser, W Arnold, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Gene therapy: prospects for treatment of liver diseaseV Sandig, C Hofmann, P Löser, et al.
Gene Therapy|November 1, 1996
HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor geneV Sandig, P Löser, A Lieber, et al.
Der Urologe. Ausg. A|November 1, 1979
[Spontaneous fistulae and abscesses of the upper urinary tract (author's transl)]E Schindler, H Zöckler, H U Braedel, et al.
Pageof 2